蔚蓝生物(603739.SH)发布前三季度业绩,归母净利润6178万元,同比增长51.24%
Vland BiotechVland Biotech(SH:603739) 智通财经网·2025-10-28 08:26

Core Insights - The company reported a revenue of 1.016 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 7.42% [1] - The net profit attributable to shareholders reached 61.78 million yuan, showing a significant year-on-year increase of 51.24% [1] - The non-recurring net profit was 22.93 million yuan, which reflects a slight decline of 1.47% year-on-year [1] - The basic earnings per share stood at 0.24 yuan [1]